|
JY231 Injection Clinical Trials
4 actively recruiting trials
Also known as: in vivo CAR-T
Pipeline
Phase 1/2: 1
Top Sponsors
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2
- Shenzhen Genocury Biotech Co., Ltd.1
- Affiliated Hospital of Guangdong Medical University1
Indications
- Cancer3
- B-Non Hodgkin Lymphoma2
- B Acute Lymphoblastic Leukemia2
- Systemic Lupus Erythematosus (SLE)1
- B-cell Malignancies1
Other4 trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.